Roger S. McIntyre

Mood Disorders Psychopharmacology Unit University Health Network, Toronto, Toronto, Ontario, Canada 
"Roger McIntyre"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lin K, Shao R, Wang R, et al. (2019) Inflammation, brain structure and cognition interrelations among individuals with differential risks for bipolar disorder. Brain, Behavior, and Immunity
Tai AMY, Albuquerque A, Carmona NE, et al. (2019) Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry. Artificial Intelligence in Medicine. 99: 101704
Cao B, Park C, Rosenblat JD, et al. (2019) Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial. Journal of Psychopharmacology (Oxford, England). 269881119874485
Yun L, Fagan M, Subramaniapillai M, et al. (2019) Are early increases in physical activity a behavioral marker for successful antidepressant treatment? Journal of Affective Disorders. 260: 287-291
Miskowiak KW, Seeberg I, Kjaerstad HL, et al. (2019) Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disorders
Ragguett RM, Tamura JK, McIntyre RS. (2019) Keeping up with the clinical advances: depression-Addendum. Cns Spectrums. 24: 84
Passos IC, Ballester P, Barros RC, et al. (2019) Machine learning and big data analytics in bipolar disorder: A Position paper from the International Society for Bipolar Disorders (ISBD) Big Data Task Force. Bipolar Disorders
Mansur RB, Lee Y, Subramaniapillai M, et al. (2019) Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalities. Bipolar Disorders
Subramaniapillai M, Mansur RB, Zuckerman H, et al. (2019) Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine. Comprehensive Psychiatry. 94: 152113
Cha DS, Luo X, Ahmed J, et al. (2019) Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics
See more...